SCHEMBL2524593

SCHEMBL2524593

COc1cc(C(=CC(=O)O)c2ccccc2)ccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
KMT2A Q03164 2/20 0.57
SLC22A6 Q4U2R8 1/20 0.57
SLC22A8 Q8TCC7 1/20 0.57
MEN1 O00255 1/20 0.57
RAB9A P51151 1/20 0.57
BLM P54132 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TSHR P16473 1/20 0.50
KDM4E B2RXH2 4/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 2/20 0.49
HSD17B2 P37059 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
HPGD P15428 1/20 0.49
RECQL P46063 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10455030 0.88 PDE4A (0.57) KMT2AMEN1RAB9ATSHRGAA
SCHEMBL10455031 0.88 PDE4A (0.57) KMT2AMEN1RAB9ATSHRGAA
SCHEMBL10386517 0.84 CYP1A2 (0.58) RAB9ATSHRGAAMAPTLMNA
SCHEMBL10386519 0.84 CYP1A2 (0.58) RAB9ATSHRGAAMAPTLMNA
SCHEMBL22208934 0.84 HTT (0.57) HTTKMT2ASLC22A6SLC22A8MEN1
SCHEMBL9367554 0.83 CA12 (0.62) TSHRKDM4EGAAMAPTLMNA
SCHEMBL10610492 0.82 TAS1R3 (0.50) HPGDCA12CA1CA2CA4
SCHEMBL10610489 0.82 TAS1R3 (0.50) HPGDCA12CA1CA2CA4
SCHEMBL2954277 0.82 TSHR (0.62) RAB9ATSHRKDM4EGAAMAPT
SCHEMBL10609792 0.81 ALDH1A1 (0.58) HTTRAB9ALMNACYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039513-B2 Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes INSTITUTE OF RADIATION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PLA (CN) 2011-10-18 US disclosed
US-7759527-B2 Microwave induced one pot process for the preparation of arylethenes COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-07-20 US disclosed
US-20080045752-A1 Microwave Induced One Pot Process For The Preparation Of Arylethenes COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045752-A1 Microwave Induced One Pot Process For The Preparation Of Arylethenes TET2, HCN4, KDM4E HTT 2179/4885KMT2A 36/4885SLC22A6 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.